The Lymphoma Research Foundation (www.lymphoma.org) has just added to its ever-growing and influential research portfolio by awarding in excess of $2 million in grants to the following researchers and research groups investigating various areas of lymphoma:
Follicular Lymphoma
John (Wing) Chan, MD,
Board of Regents of the University of Nebraska Medical Center
Oncogenic mutations in follicular and transformed follicular lymphoma
Laurence Cooper, MD
University of Texas M.D. Anderson Cancer Center
Off-The-Shelf Immunotherapy For Follicular Lymphoma Infusing CD19-Specific T Cells
David Frank, MD, PhD
Dana-Farber Cancer Institute
Identification and Targeting of Transcription Factor Pathways Activated in Follicular Lymphoma
Mantle Cell Lymphoma:
Elias Campo, MD
Institute for Biomedical Research August Pi i Sunyer (Barcelona, Spain)
Identification of Somatic Mutations in Mantle Cell Lymphoma Using Next Generation Sequencing
Samuel Katz, MD, PhD
Dana-Farber Cancer Institute
Reactivating Apoptosis in Mantle Cell Lymphoma by Peptide Replacement of the Tumor Suppressor BIM
Izidore Lossos, MD
Miller School of Medicine of the University of Miami
New Immunotherapeutic Approaches to Mantle Cell Lymphoma
Thomas Tedder, PhD
Duke University Medical Center
Molecular Insights into MCL Immunotherapy
“These grants emphasize the Foundation’s commitment to ensuring that the brightest research minds are able to pursue a cure for each of the specific types of lymphoma,” said Diane Blum, CEO of the Lymphoma Research Foundation. “We remain grateful for our supporters, whose continued confidence in our organization and the LRF mission sustains this important work.”
